These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12835802)

  • 1. Screening for prostate cancer.
    Davidson P
    N Z Med J; 2003 Jun; 116(1176):U474. PubMed ID: 12835802
    [No Abstract]   [Full Text] [Related]  

  • 2. Consent before testing men for prostate cancer--a challenge?
    Hirst G
    Aust Fam Physician; 2005 Oct; 34(10):888. PubMed ID: 16217582
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for prostate cancer: a survey of New Zealand general practitioners.
    Durham J; Low M; McLeod D
    N Z Med J; 2003 Jun; 116(1176):U476. PubMed ID: 12835804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weighing the benefits and downsides of prostate-specific antigen screening.
    Pignone M
    Arch Intern Med; 2009 Sep; 169(17):1554-6. PubMed ID: 19786672
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate cancer screening--finding the middle road forward.
    Lamb DS; Delahunt B
    N Z Med J; 2005 Feb; 118(1209):U1306. PubMed ID: 15711635
    [No Abstract]   [Full Text] [Related]  

  • 6. More on prostate cancer screening.
    Durham J
    N Z Med J; 2003 Sep; 116(1182):U612. PubMed ID: 14581961
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate cancer. Examining the risks and benefits of screening.
    Cotter VT
    Adv Nurse Pract; 1998 Jul; 6(7):51-3. PubMed ID: 9782799
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
    Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An educational workshop on the early detection of prostate cancer--a before-after evaluation.
    Steginga SK; Pinnock C; Baade PD; Jackson C; Green A; Preston J; Heathcote P; McAvoy B
    Aust Fam Physician; 2005 Oct; 34(10):889-91. PubMed ID: 16217583
    [No Abstract]   [Full Text] [Related]  

  • 11. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.
    Höltl W; Lunglmayr G
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868
    [No Abstract]   [Full Text] [Related]  

  • 12. Access to prostate cancer care and implications for survival among minorities.
    Oliver MN
    J Urol; 2009 Feb; 181(2):447-8. PubMed ID: 19095248
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate cancer testing.
    Gardner M
    Aust Fam Physician; 2003 Apr; 32(4):198; author reply 198. PubMed ID: 12735255
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective.
    Hayes JH; Barry MJ; Kantoff PW; Stahl JE
    BJU Int; 2007 Sep; 100(3):486-8. PubMed ID: 17669139
    [No Abstract]   [Full Text] [Related]  

  • 15. Can we accurately identify men with low risk prostate cancer?
    Neal DE
    J Urol; 2008 Oct; 180(4):1217-8. PubMed ID: 18707718
    [No Abstract]   [Full Text] [Related]  

  • 16. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 17. The Japanese guideline for prostate cancer screening.
    Hamashima C; Nakayama T; Sagawa M; Saito H; Sobue T
    Jpn J Clin Oncol; 2009 Jun; 39(6):339-51. PubMed ID: 19346535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do usual screening methods for prostate cancer reduce mortality?
    Manag Care Interface; 2006 May; 19(5):67. PubMed ID: 16786972
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
    Ito K
    Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors, prevention and early detection of prostate cancer.
    Loeb S; Schaeffer EM
    Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.